Regeneron PharmaceuticalsREGN 
$1,162.002.04%24h
2.04%24h
Global rank111
Market cap$124.48B
Change 7d1.55%
YTD Performance32.97%
SP500 benchmarkOutperform
P/E0
P/S9.49
Revenue$13.12B
Earnings$3.95B
Dividend yield-
Main Sector
Healthcare
Regeneron Pharmaceuticals Revenue data
According to Regeneron Pharmaceuticals latest financial reports the company had revenue of $13.12B in 2023-12-31, a 7.76% increase from 2022. Regeneron Pharmaceuticals highest revenue was $16.07B in 2021.
Revenue history for Regeneron Pharmaceuticals from 2020 to 2024
-
Value:-
Regeneron Pharmaceuticals revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $13.12B | 7.76% |
| 2022 | $12.17B | -24.26% |
| 2021 | $16.07B | 89.14% |
| 2020 | $8.50B | - |
View the top revenue stocks 
